title: Fluid flow induces upregulation of synthesis and release of tissue factor pathway inhibitor in vitro.
abstract: Fluid flow modulates the synthesis and secretion by endothelial cells (ECs) of several proteins that control the hemostatic properties of the vessel wall. Tissue factor pathway inhibitor (TFPI), also synthesized by ECs, is the main downregulator of tissue factor-dependent procoagulant activity. In the present study, we investigated the effect of physiological shear stress on the expression, distribution, and release of TFPI in cultured ECs. The EA.hy926 cell line was grown in a hollow-fiber perfusion system and exposed for variable times to different shear values: 0.27 dyne/cm(2) (minimal flow), 4.1 dyne/cm(2) (venous flow), and 19 dyne/cm(2) (moderate arterial flow). Step increase of the shear stress from 0.27 to 19 dyne/cm(2) induced a sharp increase of TFPI released into the medium and a parallel decrease and redistribution of cell-associated TFPI, which suggests that an acute release of TFPI occurred from the cellular pools. During 24 hours of high shear stress, cell-associated TFPI antigen and mRNA increased time-dependently. Subjecting ECs to steady shear stress for 72 hours also upregulated the expression and production of TFPI, in direct correlation with the degree of the shear. The secretion of TFPI was enhanced 1.9-fold under venous flow and 2.4-fold under arterial flow compared with minimal flow. Equally, cell-associated TFPI antigen and cell surface TFPI activity increased proportionally with the shear stress. The expression of TFPI mRNA, as determined by Northern blotting, increased up to 2-fold in ECs under venous flow and up to 3-fold under arterial flow. These results suggest that shear forces regulate TFPI by modulating its release and gene expression in ECs in vitro.
authors.affiliation: Vascular Biology Laboratory, Weston Centre for Experimental Research, Thrombosis Research Institute, London, UK.
authors.forename: A D
authors.initials: AD
authors.lastname: Westmuckett
authors.forename: C
authors.initials: C
authors.lastname: Lupu
authors.forename: S
authors.initials: S
authors.lastname: Roquefeuil
authors.forename: T
authors.initials: T
authors.lastname: Krausz
authors.forename: V V
authors.initials: VV
authors.lastname: Kakkar
authors.forename: F
authors.initials: F
authors.lastname: Lupu
mesh_terms: D001783:Blood Flow Velocity; D002196:Capillaries / Q000737:chemistry / Q000502:physiology / Q000648:ultrastructure; D002200:Capillary Resistance / Q000502:physiology; D002461:Cell Line, Transformed; D004730:Endothelium, Vascular / Q000737:chemistry / Q000166:cytology / Q000254:growth & development; D065427:Factor Xa Inhibitors; D006801:Humans; D008074:Lipoproteins / Q000032:analysis / Q000096:biosynthesis* / Q000097:blood / Q000378:metabolism*; D012039:Regional Blood Flow / Q000502:physiology; D013314:Stress, Mechanical; D015854:Up-Regulation / Q000502:physiology*
chemical_list: D065427:Factor Xa Inhibitors; D008074:Lipoproteins; C051928:lipoprotein-associated coagulation inhibitor